Drug Depot, Inc., dba APS Pharmacy: Drug Recall

Recall #D-0730-2022 · 03/23/2022

Class II: Risk

Recall Details

Recall Number: D-0730-2022
Classification: Class II
Product Type: Drug
Recalling Firm: Drug Depot, Inc., dba APS Pharmacy
Status: Terminated
Date Initiated: 03/23/2022
Location: Palm Harbor, FL, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 846 vials

Reason for Recall

Lack of sterility assurance.

Product Description

TESTOSTERONE CYPIONATE/ANASTROZOLE *GS* OIL 200MG/1MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 4 ML Formula ID 115387; b) (RM) 10 ML Formula ID 115125; APS Pharmacy

Distribution Pattern

Nationwide in the USA including Puerto Rico.

Other Recalls by Drug Depot, Inc., dba APS Pharmacy

Class II: Risk 03/23/2022

Lack of sterility assurance.
Class II: Risk 03/23/2022

Lack of sterility assurance.
Class II: Risk 03/23/2022

Lack of sterility assurance.
Class II: Risk 03/23/2022

Lack of sterility assurance.
Class II: Risk 03/23/2022

Lack of sterility assurance.

View all recalls by Drug Depot, Inc., dba APS Pharmacy →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.